Abuse-Deterrent Xtampza ER Approved
Krystle Vermes
The FDA has approved Collegium Pharmaceutical Inc’s oxycodone extended-release capsules (Xtampza ER) for severe pain.
Katie Eder, Director of Content
The brand name of the antidepressant Brintellix has been changed to Trintellix in order to avoid prescribing and dispensing errors related to the drug’s confusion with the blood thinner Brilinta.
Allison Gilchrist, Associate Editor
The FDA’s definition of “breakthrough” isn’t the same as Merriam-Webster’s.
Jeannette Y. Wick, RPh, MBA, FASCP
How complementary and alternative medicine contributes to polypharmacy and potentially inappropriate medication use in older cancer patients is unclear.
Rachel Lutz
Pharmacist-led collaborative care management programs for type 2 diabetes are associated with better glycemic control and lower health care costs compared with primary care settings that lack these programs.
Allison Gilchrist, Associate Editor
In honor of National Anxiety and Depression Awareness Week, pharmacists should take the time to ensure patients with anxiety are aware of the basic facts about their condition.
Krystle Vermes
The FDA has approved AstraZeneca’s glycopyrrolate and formoterol fumarate (Bevespi Aerosphere) inhalation aerosol for long-term maintenance treatment for patients with chronic obstructive pulmonary disease.
Pharmacy Times Staff
Here are the top trending pharmacy stories you might have missed in April.

Association News

The Generic Pharmaceutical Association applauds the House Appropriations Committee for approving the FY 2017 Agriculture Appropriations funding bill with provisions that would stop the Food and Drug Administration from using federal funds to finalize or implement its Proposed Rule to update generic drug labeling requirements as written.
To date, APhA has raised close to $42,000 for the organization.
ASHP recently launched a certificate program for pharmacists who are interested in expanding their roles as educators in residency programs, patient care environments, and other instructional settings.
President Barack Obama today signed into law the Ensuring Patient Access and Effective Drug Enforcement Act of 2016.

Pharmacy Market News

The Delta Foundation of Pittsburgh is pleased to announce that Mylan CEO Heather Bresch will be the first-ever CEO to participate in the Pittsburgh Pride Equality March on Sunday, June 12.
Allergan has announced that it has acquired Topokine Therapeutics, a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction.
PDX and MarkeTouch Media have announced a new integration that will incorporate the certification of the PDX EPS Patient Notification Service with MarkeTouch Media’s outbound and mobile notifications for prescription status updates.

Strategic Alliance Partner News

CVS Health has announced that it has made the opioid overdose reversal medication naloxone available without a prescription at all CVS Pharmacy locations in New Hampshire.
Hy-Vee has announced that it is once again partnering with the Pinky Swear Foundation to host six kids triathlon fundraising events across the Midwest this summer.
Latest Issues